Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does CABOTEGRAVIR Cause Injection site pain? 924 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 924 reports of Injection site pain have been filed in association with CABOTEGRAVIR (Apretude). This represents 11.1% of all adverse event reports for CABOTEGRAVIR.

924
Reports of Injection site pain with CABOTEGRAVIR
11.1%
of all CABOTEGRAVIR reports
3
Deaths
25
Hospitalizations

How Dangerous Is Injection site pain From CABOTEGRAVIR?

Of the 924 reports, 3 (0.3%) resulted in death, 25 (2.7%) required hospitalization, and 1 (0.1%) were considered life-threatening.

Is Injection site pain Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for CABOTEGRAVIR. However, 924 reports have been filed with the FAERS database.

What Other Side Effects Does CABOTEGRAVIR Cause?

Product dose omission issue (1,121) Off label use (1,049) Viral load increased (452) Pain (399) Virologic failure (275) Pathogen resistance (270) Pyrexia (255) Product use in unapproved therapeutic environment (234) Inappropriate schedule of product administration (228) Product complaint (213)

What Other Drugs Cause Injection site pain?

ADALIMUMAB (28,679) DUPILUMAB (27,799) ETANERCEPT (24,717) TIRZEPATIDE (10,989) EVOLOCUMAB (9,988) DULAGLUTIDE (9,474) GALCANEZUMAB-GNLM (6,622) HUMIRA (6,005) GLATIRAMER (5,003) LEUPROLIDE (4,678)

Which CABOTEGRAVIR Alternatives Have Lower Injection site pain Risk?

CABOTEGRAVIR vs CABOTEGRAVIR\RILPIVIRINE CABOTEGRAVIR vs CABOZANTINIB CABOTEGRAVIR vs CABOZANTINIB S-MALATE CABOTEGRAVIR vs CAFFEINE CABOTEGRAVIR vs CALASPARGASE PEGOL

Related Pages

CABOTEGRAVIR Full Profile All Injection site pain Reports All Drugs Causing Injection site pain CABOTEGRAVIR Demographics